18 brands for mental health care
The Psychiatric Division spans 18 brands across antidepressants, antipsychotics, mood stabilizers, anxiolytics, antiepileptics, and neuropathic pain therapies — supported by clinician education, adherence programs, and pharmacovigilance.
Therapeutic areas
Brand portfolio
18 brands currently marketed in the Psychiatric Division.
Depression with co-existing anxiety
Vestibular & vertigo control
First-line SSRI for depression & OCD
Atypical antipsychotic with EPS prophylaxis
Neuropathic pain & depression
Rapid-dissolve atypical antipsychotic
Anxiety with psychotic features
Anxiety-depression combination
Sleep-supporting tricyclic
Anti-epileptic and mood stabilizer support
Panic disorder & severe anxiety
Extended-release SNRI
Classic SSRI
Depression with prominent anxiety
Neuropathic pain & B12 support
Mild-moderate depression & psychosomatic disorders
Mood stabilizer for bipolar disorder
Sustained-release anticonvulsant
For full prescribing information, registered healthcare professionals can request our scientific dossier.
Request portfolio →